By Counterforce Health Team in Trikafta / Kaftrio (elexacaftor/tezacaftor/ivacaftor) —

How to Get Trikafta Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Get Trikafta Covered by UnitedHealthcare in New Jersey

Trikafta requires prior authorization from UnitedHealthcare through OptumRx. You'll need: confirmed cystic fibrosis diagnosis, CFTR genotype showing F508del or another responsive mutation, and prescription from a CF specialist. If denied, New Jersey's IHCAP program offers external review through Maximus Federal Services within 4 months. Start today: Contact your CF center to gather genotype results and baseline labs, then submit PA via UnitedHealthcare provider portal or call 866-889-8054.

Table of Contents

  1. Who Should Use This Guide
  2. Member & Plan Basics
  3. Clinical Criteria for Approval
  4. Required Documentation
  5. Submission Process
  6. Specialty Pharmacy Requirements
  7. Appeals Process in New Jersey
  8. Common Denial Reasons & Solutions
  9. Costs & Financial Assistance
  10. FAQ

Who Should Use This Guide

This guide helps patients with cystic fibrosis and their care teams navigate UnitedHealthcare's prior authorization process for Trikafta (elexacaftor/tezacaftor/ivacaftor) in New Jersey. You'll need this if:

  • Your doctor prescribed Trikafta for cystic fibrosis
  • You have UnitedHealthcare coverage (commercial, Medicare Advantage, or Medicaid managed care)
  • You received a prior authorization requirement or denial
  • You're preparing an appeal in New Jersey

Expected outcome: With proper documentation, most patients with qualifying CFTR mutations get approved. New Jersey's strong external review process gives you additional protection if initially denied.

Member & Plan Basics

Coverage Requirements

  • Prior Authorization: Required for all UnitedHealthcare plans
  • Formulary Status: Tier 3 specialty drug
  • Specialty Pharmacy: Must fill through Optum Specialty Pharmacy
  • Age Requirement: 2 years or older per FDA labeling
Note: As of May 2025, UnitedHealthcare eliminated annual reauthorization for Trikafta, allowing continued access without renewal for established users.

Plan Types Covered

  • Commercial employer plans
  • Individual marketplace plans
  • Medicare Advantage
  • Medicaid managed care (UnitedHealthcare Community Plan)

Clinical Criteria for Approval

UnitedHealthcare requires these criteria for Trikafta approval:

Primary Requirements

  1. Confirmed CF diagnosis with appropriate ICD-10 code (typically E84.0 for pulmonary manifestations)
  2. CFTR genotype showing at least one F508del mutation or another FDA-approved responsive mutation
  3. Age 2 years or older
  4. CF specialist involvement (prescription or consultation)

Laboratory Requirements

  • Baseline liver function tests (ALT, AST, bilirubin, alkaline phosphatase)
  • CFTR mutation testing from FDA-cleared laboratory
  • Documentation of liver enzymes <3x upper limit of normal

No Step Therapy Required

Unlike some medications, Trikafta doesn't require trying other CFTR modulators first, though prior therapy history should be documented.

Required Documentation

Medical Necessity Letter Components

Your CF specialist should include:

Patient Information

  • Full name, date of birth, member ID
  • CF center and treating physician details

Diagnosis Confirmation

  • Cystic fibrosis diagnosis with ICD-10 code
  • Diagnostic basis (newborn screen, sweat chloride, clinical features)
  • Sweat chloride results if available (≥60 mmol/L supports classic CF)

CFTR Genotype Documentation

  • Complete genotype report with testing dates
  • Explicit statement: "Patient has at least one F508del mutation" or specific responsive variant
  • Confirmation this genotype is FDA-approved for Trikafta

Clinical Status

  • Recent pulmonary function tests (FEV1, FVC with percentiles)
  • Exacerbation history (hospitalizations, IV antibiotics in past 12 months)
  • BMI/nutritional status
  • Other CF complications (diabetes, liver disease, sinus disease)

Treatment History

  • Current CF therapies (airway clearance, inhaled medications, PERT)
  • Prior CFTR modulators if applicable (dates, response, tolerability)
  • Statement of ongoing disease burden despite optimal therapy

Supporting Documents Checklist

  • CFTR genotype laboratory report
  • Recent pulmonary function tests
  • Baseline liver function tests
  • Sweat chloride results (if available)
  • CF specialist consultation notes
  • Prior authorization form (completed)

Submission Process

Step-by-Step Submission

  1. Gather Documentation (Patient/Family)
    • Contact CF center for genotype results and recent test results
    • Ensure all baseline labs are current
  2. Complete Prior Authorization (CF Specialist)
  3. Track Submission (Clinic Staff)
    • Record confirmation number
    • Standard review: 72 hours
    • Expedited review: 24-72 hours for urgent cases
  4. Verify Approval (Patient/Family)
    • Check member portal for status updates
    • Contact Optum Specialty Pharmacy once approved

Required Forms

Specialty Pharmacy Requirements

Optum Specialty Pharmacy

Trikafta must be dispensed through UnitedHealthcare's preferred specialty pharmacy:

Contact Information:

  • Phone: 1-855-427-4682
  • Available 24/7 for pharmacist consultation

Services Included:

  • Prescription transfer assistance
  • Overnight shipping
  • Refill reminders
  • Clinical support programs
  • Copay assistance coordination

Transfer Process

  1. Obtain prior authorization approval
  2. Prescriber sends script to Optum Specialty
  3. Pharmacy contacts patient for enrollment
  4. Coordinate delivery and payment setup

Appeals Process in New Jersey

Internal Appeals (File within 180 days)

Stage 1 (All Plans):

  • Submit to UnitedHealthcare medical director
  • Include detailed rebuttal addressing denial reasons
  • Timeline: 72 hours for urgent cases, 10 days standard
  • Use UnitedHealthcare UM Appeal Review form

Stage 2 (Group Plans Only):

  • Independent panel review
  • File within 180 days of Stage 1 denial
  • Timeline: 72 hours urgent, 20 business days standard

New Jersey External Review (IHCAP)

After completing internal appeals, New Jersey residents can request external review through the Independent Health Care Appeals Program.

Managed by: Maximus Federal Services Contact: 888-866-6205 or [email protected] Deadline: 4 months from final internal denial Cost: Free to patients

Process:

  1. Submit appeal with all documentation
  2. Preliminary review within 5 business days
  3. Specialty physician panel review
  4. Decision within 45 days (expedited available)
  5. Binding decision on insurer
From our advocates: In our experience, external reviews in New Jersey often favor patients when strong clinical documentation supports medical necessity. The key is addressing each specific denial reason with evidence-based responses and current clinical guidelines.

Common Denial Reasons & Solutions

Denial Reason Solution Required Documents
Missing CFTR genotype Submit FDA-cleared test results Laboratory genotype report
Insufficient baseline labs Provide current lab values Liver function tests, CBC
Not medically necessary Strengthen clinical justification Enhanced provider letter, guidelines
Age requirement not met Verify patient age ≥2 years Birth certificate, medical records
Drug interactions Document interaction review Medication list, safety assessment

Appeals Strategy Tips

  • Address each denial reason point-by-point
  • Include current Cystic Fibrosis Foundation guidelines
  • Reference FDA labeling for approved mutations
  • Document disease progression despite optimal therapy
  • Request expedited review if clinically urgent

Costs & Financial Assistance

Insurance Coverage

  • Tier 3 Specialty: Typically 25-40% coinsurance
  • Annual list price: Approximately $369,000
  • Deductible applies: Most plans require meeting deductible first

Financial Assistance Options

  • Vertex Patient Services: Copay assistance and case management
  • CF Foundation Compass: Financial assistance program
  • New Jersey pharmaceutical assistance programs
  • Medicaid coverage for eligible patients

For comprehensive support navigating insurance denials and appeals, Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned to each payer's specific requirements.

FAQ

How long does UnitedHealthcare prior authorization take in New Jersey? Standard review takes 72 hours, with expedited review available in 24-72 hours for urgent cases.

What if Trikafta is non-formulary on my plan? Trikafta is typically covered as Tier 3 specialty. If listed as non-formulary, request a formulary exception with strong medical necessity documentation.

Can I appeal if I've tried other CFTR modulators outside New Jersey? Yes, document all prior therapy attempts regardless of where they occurred. This strengthens your medical necessity case.

Does step therapy apply to Trikafta? No explicit step therapy is required in UnitedHealthcare's core criteria, though some plans may have variations.

What if my CF specialist isn't in-network? You may need a referral or prior authorization for out-of-network specialist consultation. Contact UnitedHealthcare to verify requirements.

How do I request expedited review? Contact your CF specialist to document clinical urgency (declining lung function, frequent exacerbations) and request expedited processing.

What happens if external review favors coverage? UnitedHealthcare must comply with the external review decision and provide coverage as directed.

Can I get Trikafta at a retail pharmacy? No, UnitedHealthcare requires specialty pharmacy dispensing through Optum Specialty Pharmacy.

Sources & Further Reading

Disclaimer: This information is for educational purposes and does not constitute medical or legal advice. Coverage policies vary by plan and may change. Always verify current requirements with UnitedHealthcare and consult your healthcare provider for medical decisions. For assistance with complex appeals, contact the New Jersey Department of Banking and Insurance or consider working with Counterforce Health for specialized insurance appeals support.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.